Investigational Drug Information for Onapristone
✉ Email this page to a colleague
What is the drug development status for Onapristone?
Onapristone is an investigational drug.
There have been 10 clinical trials for Onapristone.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2008.
The most common disease conditions in clinical trials are Breast Neoplasms, Endometrial Neoplasms, and Prostatic Neoplasms. The leading clinical trial sponsors are Context Therapeutics, Arno Therapeutics, and Memorial Sloan Kettering Cancer Center.
Summary for Onapristone
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 4,713 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 2,032 |
| Clinical Trial Progress | Phase 2 (2008-03-01) |
| Vendors | 23 |
Recent Clinical Trials for Onapristone
| Title | Sponsor | Phase |
|---|---|---|
| Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer | Context Therapeutics Inc. | Phase 1/Phase 2 |
| Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study) | Context Therapeutics | Phase 2 |
| Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study) | University of Wisconsin, Madison | Phase 2 |
Clinical Trial Summary for Onapristone
Top disease conditions for Onapristone
Top clinical trial sponsors for Onapristone
US Patents for Onapristone
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
